[HTML][HTML] Prognosis of HIV patients receiving antiretroviral therapy according to CD4 counts: a long-term follow-up study in Yunnan, China

L Ren, J Li, S Zhou, X Xia, Z Xie, P Liu, Y Xu, Y Qian… - Scientific reports, 2017 - nature.com
We aim to evaluate the overall survival and associated risk factors for HIV-infected Chinese
patients on antiretroviral therapy (ART). 2517 patients receiving ART between 2006 and …

African descent is associated with slower CD4 cell count decline in treatment-naive patients of the Swiss HIV Cohort Study

V Müller, V von Wyl, S Yerly, J Böni, T Klimkait… - Aids, 2009 - journals.lww.com
Objective: We investigated the effect of descent (African versus European) on the
progression of untreated HIV infections in a prospective cohort study of HIV-1-infected …

[HTML][HTML] Clinical progression rates by CD4 cell category before and after the initiation of combination antiretroviral therapy (cART)

M Guiguet, K Porter, A Phillips, D Costagliola… - The Open AIDS …, 2008 - ncbi.nlm.nih.gov
Objective Rates of AIDS defining event (ADE), serious ADE and death by CD4 and HIV RNA
categories before and after combination antiretroviral therapy (cART) initiation are lacking …

[HTML][HTML] CD4 T-cell declines by ethnicity in untreated HIV-1 infected patients in South Africa and Switzerland

M May, R Wood, L Myer, P Taffé, A Rauch… - The Journal of …, 2009 - ncbi.nlm.nih.gov
Background Estimates of the decline in CD4 cell counts in untreated HIV-infected patients
are important for patient care and public health. We analyzed declines in the Cape Town …

Clinical outcomes and risk factors for immune recovery and all‐cause mortality in Latin Americans living with HIV with virological success: a retrospective cohort study

G Castillo‐Rozas, S Tu, PM Luz, F Mejia… - Journal of the …, 2024 - Wiley Online Library
Introduction Immune reconstitution following antiretroviral therapy (ART) initiation is crucial
to prevent AIDS and non‐AIDS‐related comorbidities. Patients with suppressed viraemia …

The prognostic value of baseline CD4+ cell count beyond 6 months of antiretroviral therapy in HIV-positive patients in a resource-limited setting

EJ Mills, C Bakanda, J Birungi, S Yaya, N Ford… - Aids, 2012 - journals.lww.com
Objective: The risk of death is highest in the first few months after initiation of antiretroviral
therapy (ART). We examined whether initial CD4+ cell count maintains a strong prognostic …

[HTML][HTML] Estimation of the duration between HIV seroconversion and HIV diagnosis in different population groups in French Guiana: Strategic information to reduce the …

M Nacher, A Adenis, F Huber, E Hallet, P Abboud… - PLoS …, 2018 - journals.plos.org
Background Given the great efforts put into the strategic objective of reducing the proportion
of HIV-infected patients that are undiagnosed, the aim of the present study was to review the …

How have ART treatment programmes changed the patterns of excess mortality in people living with HIV? Estimates from four countries in East and Southern Africa

E Slaymaker, J Todd, M Marston, C Calvert… - Global health …, 2014 - Taylor & Francis
Background Substantial falls in the mortality of people living with HIV (PLWH) have been
observed since the introduction of antiretroviral therapy (ART) in sub-Saharan Africa …

CD4 count slope and mortality in HIV-infected patients on antiretroviral therapy: multicohort analysis from South Africa

CJ Hoffmann, M Schomaker, MP Fox… - JAIDS Journal of …, 2013 - journals.lww.com
Background: In many resource-limited settings monitoring of combination antiretroviral
therapy (cART) is based on the current CD4 count, with limited access to HIV RNA tests or …

HIV-1 disease progression and mortality before the introduction of highly active antiretroviral therapy in rural Uganda

L Van der Paal, LA Shafer, J Todd, BN Mayanja… - Aids, 2007 - journals.lww.com
Objective: To provide estimates of survival and progression to different HIV disease
endpoints after HIV infection among adults in a rural Ugandan setting. Design: A prospective …